Aida Santaolalla Revenga

Biosketch: I have a degree Biochemistry awarded by the University of Granada (UG, Spain). While studying my degree, I attended to computer-based biology labs that both delighted me and changed my perspective about the professional career routes in the biomedical field. Influenced by that first approach to computational biology, I carried out a Master in Bioinformatics for Health Sciences, at the University Pompeu Fabra, Barcelona (UPF, Spain) after completing my degrees in 2003. While doing my masters, I had a Research Fellowship at the Molecular Evolution Research Group in the Molecular Biology Institute Barcelona IBMB (CSIC) awarded by La Caixa in 2005. In the master project, I developed a web-interface and an epidemiological database to collect clinical data for a governmental project, IMIDKit, a Genome Wide Association Study of Immune Mediated Diseases. That project was conducted in the Barcelona Supercomputing Center (BSC) where I was hired to maintain and support the project and other projects until 2009. After the completion of the project, I moved to Seville and worked in a system biology project modelling biochemical pathways to optimise the production of ectoines by the organism Chromohalobacter salexigen in the University of Seville (US, Spain). In 2011, I was appointed to a position as a Prostate Cancer (PCa) data manager and data analyst in the Cancer Epidemiology Group in King’s College London (KCL, UK). During the last five years in this role, I have worked to establish the King’s Health Partners PCa Biobank, that currently collects surplus and research only tissue material and data from the PCa patients in Guy’s and St Thomas’ NHS trust (GSTT), and to develop and maintain a GSTT PCa patient’s database for research purposes. Both resources are currently being utilized in different research projects, national and international, where we also participate on the design and analytical phases. In parallel, I am doing a PhD in Biostatistics focus in data reduction methods applied to biomedical data also in King’s College London (KCL, UK), more specifically I have conducted two main studies, a clinical project that aim to study blood serum markers as possible predictors of cancer outcomes and a imaging project that study the feasibility of the usage of a terahertz probe in Breast-conserving surgery to discriminate tumour margins in the operating theatre.